Background: Primary sarcomas originating from the bones of hand and wrist are rare but carry a significant burden of morbidity.
Methods: National Cancer Institute's Surveillance, Epidemiology and End Result database from 1975 to 2017 was queried to report incidence and survival data in 237 patients in the United States. Kaplan-Meier and Cox regression were used to determine the prognostic factors affecting survival. χ 2 test was used to assess the correlation.Results: Incidence of hand and wrist sarcoma was 0.017 per 100 000 persons in 2017 and has not significantly changed since 1975 (p > 0.05). Disease-specific 5-year and 10-year survival for the entire cohort was 90% and 84%, respectively. On multivariate analysis race "others," histology other than "osteosarcoma," "undifferentiated" grade, and size "≥6 cm" were predictors of worse disease-specific survival. Cross-tabulation of race with other significant prognostic factors on univariate analysis revealed a significant correlation of race with every other significant prognostic factor except for grade.
Conclusions:The current study is an analysis of a population-based registry reporting incidence and survival data for patients with sarcoma of hand and wrist.Independent prognostic factors include race, histology, grade, and size. There is a lack of improvement in survival over the last four decades. How to cite this article: Jawad MU, Bayne CO, Farhan SB, et al. Prognostic factors, disparity, and equity variables impacting prognosis in bone sarcomas of the hand: SEER database review.